Immune-mediated myocarditis in Fabry disease cardiomyopathy causes disease progression and resistance to enzyme replacement therapy. Influence of immunosuppressive therapy
- 4 Anni 2019/2023
- 160.500€ Totale Fondi
Abstract non disponibile
Pubblicazioni Scientifiche
- ESC HEART FAILURE
Fabry cardiomyopathy: Gb3-induced auto-reactive panmyocarditis requiring heart transplantation
- ESC HEART FAILURE
Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy
- JOURNAL OF CLINICAL MEDICINE
Divergent Impact of Enzyme Replacement Therapy on Human Cardiomyocytes and Enterocytes Affected by Fabry Disease: Correlation with Mannose-6-phosphate Receptor Expression
- JOURNAL OF NEUROSCIENCE
p140Cap Regulates the Composition and Localization of the NMDAR Complex in Synaptic Lipid Rafts
- JOURNAL OF THE AMERICAN HEART ASSOCIATION
Immune-Mediated Myocarditis in Fabry Disease Cardiomyopathy
- ORPHANET JOURNAL OF RARE DISEASES
Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
